Inmune Bio (INMB) Other Gross PP&E Adjustments (2019 - 2025)
Inmune Bio (INMB) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with -$4.0 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 63.9% to -$4.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.0 million through Dec 2025, down 63.9% year-over-year, with the annual reading at -$4.0 million for FY2025, 63.9% down from the prior year.
- Other Gross PP&E Adjustments hit -$4.0 million in Q4 2025 for Inmune Bio, down from -$1.1 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$128000.0 in Q3 2021 to a low of -$4.0 million in Q4 2025.
- Historically, Other Gross PP&E Adjustments has averaged -$923500.0 across 5 years, with a median of -$485000.0 in 2023.
- Biggest five-year swings in Other Gross PP&E Adjustments: crashed 374.45% in 2022 and later soared 33.2% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at -$795000.0 in 2021, then tumbled by 138.11% to -$1.9 million in 2022, then tumbled by 38.51% to -$2.6 million in 2023, then increased by 6.6% to -$2.4 million in 2024, then crashed by 63.9% to -$4.0 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for INMB at -$4.0 million in Q4 2025, -$1.1 million in Q3 2025, and -$374000.0 in Q2 2025.